MedicaidPrior AuthMedium impact
BT202092: Pharmacy update approved by Drug Utilization Review Board July 2020
Indiana Medicaid (IHCP)·IN · Endocrinology, OB-GYN, Psychiatry +2 more·Prior Authorization
Effective date
Sep 1, 2020
We identified it
Jun 19, 2026
Summary
Indiana Medicaid removed prior authorization requirements for Gonadotropin Releasing Hormone (GnRH) Agents and oral Buprenorphine for opioid use disorder treatment. These medications no longer require prior approval for fee-for-service Indiana Medicaid patients.
Action Required
By September 1, 2020: Billing team must update prior authorization workflows to remove PA requirements for GnRH agents and oral buprenorphine for opioid use disorder for Indiana Medicaid fee-for-service patients. Update billing system rules and staff training to reflect that these medications can now be prescribed without prior approval.